Publication | Closed Access

Promoter methylation, mutation, and genomic deletion are involved in the decreased NDRG2 expression levels in several cancer cell lines

Genomic DeletionMedicineGeneticsEpigenetic ChangeEpigenomicsCancer GenomicsPromoter MethylationGene ExpressionCancer BiologyCell BiologyEpigeneticsCancer Research